Literature DB >> 6618970

Serodiagnosis of western equine encephalitis virus infections: relationships of antibody titer and test to observed onset of clinical illness.

C H Calisher, J K Emerson, D J Muth, J S Lazuick, T P Monath.   

Abstract

Sera from horses and human beings with clinically diagnosed western equine encephalitis (WEE) virus infections were tested for hemagglutination-inhibition (HI), complement-fixation (CF), and neutralizing (N) antibody to WEE virus. These tests confirmed infection in 43.8% (HI), 56.3% (CF), and 80.4% (N) of horses and 54.5% (HI), 59.1% (CF), and 77.3% (N) of human beings. Use of the N test as an adjunct to the HI and CF tests increased the likelihood of serologic confirmation to 91.7%. In both horses and human beings, N antibody increased steeply at the end of the 1st week after onset. The results suggested that the presence of a high HI, CF, and/or N antibody titer in a single serum obtained from horses during the acute phase of illness caused by WEE virus can be used as presumptive evidence for infection with this virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618970

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Impact of climate on western equine encephalitis in Manitoba, Minnesota and North Dakota, 1980-1983.

Authors:  R F Sellers; A R Maarouf
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

2.  Weather factors in the prediction of western equine encephalitis epidemics in Manitoba.

Authors:  R F Sellers; A R Maarouf
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

3.  Equine viral encephalomyelitis in Canada: a review of known and potential causes.

Authors:  D P Keane; P B Little
Journal:  Can Vet J       Date:  1987-08       Impact factor: 1.008

4.  Neutralising antibodies for Mayaro virus in Pantanal, Brazil.

Authors:  Alex Pauvolid-Corrêa; Raquel Soares Juliano; Zilca Campos; Jason Velez; Rita Maria Ribeiro Nogueira; Nicholas Komar
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-03       Impact factor: 2.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.